Public issue of 14,00,000 equity shares of Rs. 10 each ("Equity Shares") of Dr Lalchandani Labs Limited ("DLCL" or The "Company" or The "Issuer") for cash at a price of Rs. 30 per share (The "Issue Price"), aggregating to Rs. 4.20 crores ("The Issue"), of which, 72,000 equity shares of Rs. 10 each will be reserved for subscription by market makers to the issue (The "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. Issue of 13,28,000 equity shares of Rs. 10 each is hereinafter referred to as the "Net Issue". The issue and the net issue will constitute 32.31% and 30.65%, respectively of the post issue paid up equity share capital of the company.
The Face value of the equity shares is Rs. 10 each and the issue price of Rs. 30/- i.e. 3.00 (Three) time of the face value of the equity shares.
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
25-Apr-2018
27-Apr-2018
₹ 30.00
₹ 0.00
Minimum Application for shares in Nos : 4000.0
Further Multiples of : 4000.0
(₹)Cr.
Lead Managers to the Issue
Project Cost
4.20
Navigant Corporate Advisors Ltd
Project Financed through Current Offer
4.20
Post Issue Equity Share Capital
4.33
Issue Price
₹30.00
Projects
To open second major processing center (2000 sq. ft. area) in Delhi/NCR
Repayment / pre-payment, in full or part, of certain borrowings availed by the company
To purchase advanced machinery and equipment
To open new collection centers based on COCO model
To Develop E-Applications and E Programs and other I.T. support systems
For Recruitment, Training and Placement of staff to expand operations and other operational expenses